Table 1 Description of the participants included in the study
Glycohemoglobin | < 7 N = 2939 | ≥7 N = 232 | All N = 3171 | P-value |
|---|---|---|---|---|
Age (years) | 46.27 ± 16.77 | 57.37 ± 13.53 | 46.86 ± 16.80 | < 0.0001 |
ALT(U/L) | 25.85 ± 46.66 | 33.63 ± 25.83 | 26.26 ± 45.83 | 0.0329 |
Cr (umol/L) | 77.13 ± 29.41 | 77.96 ± 26.38 | 77.18 ± 29.26 | 0.7215 |
γGT (IU/L) | 28.49 ± 40.77 | 44.17 ± 43.89 | 29.32 ± 41.09 | < 0.0001 |
Glu (mg/dL) | 93.54 ± 16.56 | 191.86 ± 70.91 | 98.73 ± 31.76 | < 0.0001 |
sUA (mg/dL) | 5.35 ± 1.46 | 5.39 ± 1.25 | 5.35 ± 1.45 | 0.7932 |
TG (mg/dL) | 120.71 ± 85.30 | 187.58 ± 203.12 | 124.78 ± 97.97 | < 0.0001 |
LDL (mg/dL) | 116.11 ± 34.71 | 109.60 ± 37.31 | 115.74 ± 34.90 | 0.0945 |
TC (mg/dL) | 195.14 ± 40.41 | 199.99 ± 77.05 | 195.39 ± 43.14 | 0.1563 |
HDL-C (mg/dL) | 53.79 ± 16.25 | 44.84 ± 12.93 | 53.31 ± 16.22 | < 0.0001 |
glycohemoglobin (%) | 5.42 ± 0.43 | 8.53 ± 1.54 | 5.58 ± 0.89 | < 0.0001 |
BMI (kg/m2) | 28.20 ± 6.32 | 32.12 ± 7.28 | 28.42 ± 6.43 | < 0.0001 |
Waist circumference (cm) | 96.38 ± 14.98 | 108.57 ± 16.76 | 97.02 ± 15.32 | < 0.0001 |
SBP (mmHg) | 118.39 ± 16.41 | 118.62 ± 14.41 | 118.40 ± 16.31 | 0.8585 |
DBP (mmHg) | 66.08 ± 13.28 | 64.75 ± 15.08 | 66.01 ± 13.39 | 0.2121 |
Sex(%) | 0.0906 | |||
Male | 47.53 | 54.24 | 47.88 | |
Female | 52.47 | 45.76 | 52.12 | |
Race/ethnicity (%) | 0.0598 | |||
Mexican American | 7.88 | 13.30 | 8.17 | |
Other race/ethnicity | 13.09 | 13.32 | 13.10 | |
Non-Hispanic White | 68.42 | 61.05 | 68.03 | |
Non-Hispanic Black | 10.61 | 12.33 | 10.70 | |
Age groups (%) | < 0.0001 | |||
Age < 40 years | 39.82 | 8.61 | 38.17 | |
Age > =40, < 60 years | 36.37 | 42.58 | 36.70 | |
Age > =60 years | 23.81 | 48.81 | 25.13 | |
Medications | ||||
Lipid-lowering medications | 74.17 | 33.23 | < 0.0001 | |
Anti-diabetic medications | 73.43 | 36.68 | < 0.0001 | |